ArticleResearch and practice in thrombosis and haemostasis2026
Neutrophil-to-lymphocyte ratio is associated with 30-day mortality in acute pulmonary embolism across European Society of Cardiology risk categories.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality. The neutrophil-to-lymphocyte ratio (NLR) is a readily available biomarker reflecting inflammatory stress responses and has been proposed as a predictor of cardiovascular outcomes. Objectives: This study evaluated the association between elevated NLR and 30-day all-cause mortality in patients with acute PE across European Society of Cardiology (ESC) risk categories. Methods: A retrospective cohort study of adults with acute PE diagnosed by computed tomography pulmonary angiography was conducted within an integrated health system from January 2019 to January 2025. NLR was calculated from admission complete blood counts and categorized as elevated using a prespecified cutoff (≥7). Patients were stratified by ESC risk category. Multivariable logistic regression was used to assess association between elevated NLR and 30-day mortality, adjusting for age, sex, cancer status, and congestive heart failure. Results: Among 1525 patients with acute PE, 46.4% were ESC low risk, 51.7% intermediate risk, and 1.9% high risk; 30-day all-cause mortality occurred in 6.6% of patients and was markedly higher among patients with elevated NLR in the ESC low-risk (10.4% vs 1.2%) and intermediate-risk (16.2% vs 3.6%) groups. Elevated NLR was independently associated with increased mortality in ESC low-risk (odds ratio, 5.68; 95% CI, 2.09-15.44) and intermediate-risk patients (odds ratio, 4.60; 95% CI, 2.57-8.24). Addition of NLR to the ESC-based model improved discrimination for 30-day mortality (C-statistic, 0.812-0.853; Conclusion: Elevated NLR is independently associated with increased 30-day all-cause mortality in patients with acute pulmonary embolism classified as ESC low or intermediate risk. Consequently, NLR may serve as a simple adjunctive marker for refining PE risk stratification; however, prospective validation is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.